Showing results (131-140 of 232) with videos related to

Sort By:
Pageof 24
Clinical Pharmacology in Drug Development|April 30, 2016
Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler deviceTeddy Kosoglou, James Hubbell, Amy O Johnson-Levonas, et al.
The Journal of Bone and Joint Surgery. British Volume|June 2, 2007
The factors affecting outcome after non-vascular bone grafting and internal fixation for nonunion of the scaphoidC Ramamurthy, L Cutler, D Nuttall, et al.
The Laryngoscope|December 9, 2003
Results of Caldwell-Luc after failed endoscopic middle meatus antrostomy in patients with chronic sinusitisJeffrey L Cutler, James A Duncavage, Keith Matheny, et al.
British Journal of Clinical Pharmacology|June 9, 2007
Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiencySamir K Gupta, Suzanne K Swan, Thomas Marbury, et al.
Community Mental Health Journal|January 1, 1987
Academic, community and state mental health program collaboration: the Oregon experienceL R Faulkner, J D Bloom, D L Cutler, et al.
The EMBO Journal|November 15, 1995
Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activationJ E Damen, H Wakao, A Miyajima, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 26, 2013
Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary diseaseTeddy Kosoglou, James Hubbell, Fengjuan Xuan, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|August 7, 2019
Long-term Outcomes of Balloon Dilation for Persistent Eustachian Tube DysfunctionJeffrey L Cutler, Ted A Meyer, Shaun A Nguyen, et al.
Clinical Pharmacology in Drug Development|April 14, 2017
No Pharmacokinetic Drug-Drug Interaction Between Prasugrel and Vorapaxar Following Multiple-Dose Administration in Healthy VolunteersMatt S Anderson, Teddy Kosoglou, Paul Statkevich, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trialTeddy Kosoglou, Thomas L Hunt, Fengjuan Xuan, et al.
Pageof 24